情感(语言学)
细胞因子
管道(软件)
医学
免疫学
药理学
心理学
计算机科学
沟通
程序设计语言
出处
期刊:Cancer Discovery
[American Association for Cancer Research]
日期:2022-05-12
卷期号:12 (7): 1604-1605
被引量:8
标识
DOI:10.1158/2159-8290.cd-nb2022-0036
摘要
The engineered IL2 cytokine bempegaldesleukin fell flat in multiple late-stage clinical studies, prompting its developers-Nektar Therapeutics and Bristol Myers Squibb-to halt its clinical development. However, a pipeline of diverse IL2-based therapies may yet succeed.
科研通智能强力驱动
Strongly Powered by AbleSci AI